FridayOct 22, 2021 9:30 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Playing a Leadership Role in Point-of-Care Diagnostics Space

Avricore is a leader in the health diagnostics space offering the most sophisticated and complete solution for pharmacy today The company is also leading a charge aimed at saving lives and money spent on health care Avricore partnered with Abbott Diagnostics becoming the first third-party technology company to hold distribution agreements with the manufacturer Avricore is currently entering a period of epic growth Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a health diagnostics technology innovator, is a leader in the point-of-care (“POC”) diagnostics space and a company of several firsts. Through its flagship platform and eponymous wholly owned subsidiary, HealthTab(TM), Avricore…

Continue Reading

WednesdayOct 20, 2021 1:16 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Platform Helping Reduce Patient Care Costs, Waiting Time

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) understands that up to 70% of all medical decisions are based on lab tests, which account for between 3% and 6% of total patient-care costs. The amount can be even more significant if a patient requires multiple tests or if the initial test proves unforthcoming. Avricore — which is focused on developing a network of point-of-care analyzers, offering advanced technologies that aid with easy, fast and efficient diagnosis — utilizes its HealthTab(TM) platform in community pharmacies, rural areas and workplaces to cut down on the time it takes for a patient to get a…

Continue Reading

MondayOct 18, 2021 12:58 pm

Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Value-Added Services Driving Better Patient Outcomes

Avricore, through its HealthTab(TM) flagship offering, is bringing health diagnosis and treatment closer to people The point-of-care testing market, which Avricore is part of, shows incredible potential for growth in the coming years Strategic investments and critical partnerships with other key players in the industry have allowed Avricore to stand out among its competitors This has also enabled the company to create value for stakeholders and better outcomes for patients The point-of-care testing market is projected to be valued at $50.6 billion by 2025, up from $29.5 billion in 2020. This will represent a compounded annual growth rate (“CAGR”) of…

Continue Reading

ThursdayOct 14, 2021 2:11 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Featured in Audio Broadcast Discussing Real-World Data and Healthcare

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, is at the center of the discussion of healthcare and real-world data in a recent NetworkNewsAudio release. The broadcast, titled “Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner,” notes that insurers, healthcare providers, life sciences companies and governments alike face challenges such as rising costs and inconsistent outcomes. Evidence points toward real-world data, which is more accurate and cost efficient, making a positive impact on these challenges. The audio broadcast also mentioned that younger generations of patients are…

Continue Reading

TuesdayOct 12, 2021 2:57 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Flagship Offering Helping Patients Take Steps to a Healthier Future

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is providing direct access to lab-accurate tests that measure and monitor conditions such as heart disease and diabetes, thereby leveraging health trends that note that consumers are increasingly taking health into their own hands. According to a recent McKinsey report, consumers are increasingly reliant on devices that help them monitor their own health and symptoms between doctor’s appointments. A recent article reads, “Through its flagship offering and wholly owned subsidiary, HealthTab(TM), the company turns pharmacies into community diagnostic centers by providing a turnkey point-of-care testing platform. The platform, which brings these analyzers into a…

Continue Reading

FridayOct 08, 2021 2:21 pm

Podcast Interview Highlights POC Health Data Testing Using Innovative Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Platform

Pharmacy services developer Avricore Health recently completed the initial phase of rolling out its HealthTab(TM) platform HealthTab(TM) partners with other health technology platforms to collect data from blood or other molecular samples to test them for illnesses ranging from COVID and flu to heart disease and diabetes Avricore’s platform is designed to not only provide medical condition information to patients, but to share it seamlessly with medical providers and researchers The company’s initial rollout took place through pharmacies in Ontario, Canada, but Avricore intends to continue expanding throughout Canada, into the United States and eventually into Europe Health diagnostics technology…

Continue Reading

TuesdayOct 05, 2021 11:55 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Featured in Latest Episode of ‘Bell2Bell’ Podcast

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Avricore Health’s CEO Hector Bremner joined the latest episode to discuss the company’s business model and its continuing efforts to lead the charge and improve early detection and screening practices throughout the health care industry. “We’re a company focused on diagnostics. We place a system within the pharmacy where a blood test or a molecular test can be done. A simple sample is collected, and the whole test takes about 15 minutes,”…

Continue Reading

MondayOct 04, 2021 9:00 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Taking Part in Health Care Digital Transformation Through HealthTab(TM) Platform

Through HealthTab, its flagship offering, Avricore is enabling consumers to access important health information in a convenient way and at a time that is fitting for them HealthTab is a turnkey point-of-care testing solution that combines a secure, cloud-based platform with point-of-care technologies In a rapidly evolving world of healthcare that has seen consumers become more health-conscious and prompted the adoption of digital technologies, Avricore is playing a critical role Avricore has appointed Oak Hill Financial Services Inc. to provide the company with investor relations and advisory services. When reflecting upon the impact of the COVID-19 pandemic, it is hard…

Continue Reading

ThursdaySep 30, 2021 12:40 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Simplifying Patients’ Lives with Easy Access to Point-of-Care Testing

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has remained committed to becoming the world’s largest health data company, as evidenced by its move to innovate and leverage specific point-of-care technologies within its community of pharmacies. It has also partnered with Abbott Canada, Shoppers Drug Mart and Ellerca Health in a bid to facilitate its growth and make its technology and services accessible to as many people as possible. “Avricore’s flagship platform, HealthTab(TM), impacts the healthcare sector mainly by simplifying patients’ lives with easy access to point-of-care testing,” reads a recent article. “With HealthTab, Avricore can offer pharmacies complete turnkey and point-of-care…

Continue Reading

FridaySep 24, 2021 9:15 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) and the Critical Need for Better Disease Diagnosis

Up to 70% of all medical decisions are based on lab tests. These tests cost between 3% and 6% of total patient-care costs The average patient spends about $260 on lab tests, a figure that is mainly associated with waiting for test results With point-of-care (“POC”) testing, waiting time can improve by as much as 46 minutes per patient, thus making it cheaper for the patient Avricore understands this problem, hence its investment in point-of-care technologies designed to make disease diagnosis easier, affordable, and more efficient Over the past few decades, disease diagnosis has proven to be the single most…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered